Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Our study has identified AEs associated with laronidase that could provide support for clinical monitoring and risk identification of laronidase.
Authors
- Jinyu Xue (ORCID: https://orcid.org/0000-0002-8328-6424)
- Xin Yu (ORCID: https://orcid.org/0000-0002-0269-5649)
- Zhuomiao Lin
- Jiahong Zhong
- Meiqing Yang
Institutions
- Chinese University of Hong Kong (HK)
- Shantou University (CN)
- Meizhou City People's Hospital (CN)
- Second Affiliated Hospital of Shantou University Medical College (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.3389/fphar.2025.1623921
- Citations
- 2
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation